Novo Nordisk has a history of marketing drugs under different names for treatments of obesity and diabetes, respectively. Novo Nordisk's biggest competitor, Eli Lilly, is now pondering a similar move, writes industry media Fiercepharma.
The US-based company is targeting the same markets as Novo's drug, semaglutide, which is branded as either Ozempic or Wegovy depending on whether the treatment is for diabetes or obesity. Eli Lilly is considering the same approach, said the company's CEO, Dave Ricks, at J.P. Morgan's annual healthcare conference.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Bavarian Nordic ramps up monkeypox vaccine production
CEO Paul Chaplin reports that Bavarian is making more doses of its vaccine against monkeypox due to the recent outbreak.
Carb-X secures USD 370m in fight against antibiotic resistance
International antibiotic alliance Carb-X has received commitments of up to USD 370m to accelerate the development of new antibiotics to combat a future shortage. The news is welcomed by several players on the AMR field.
Former Ambu CEO's equity investments end in USD 2m losses
Juan Jose Gonzalez, who was the CEO of medtech firm Ambu until very recently, has lost just over DKK 16m (USD 2.3m) before taxes on his share purchases.
Jesper Høiland retires as chief commercial officer of Ascendis Pharma
Former executive vice president of Novo Nordisk, US, Jesper Høiland has decided to step down from his role as global chief commercial officer at Ascendis Pharma.
ALK finds replacement for long-time North America lead
Jorge Alderete, ALK’s president in North America, is leaving the firm after 23 years. He will be replaced by Hans Lindeberg, ALK’s current head of the Nordic region.
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Clinical Trial Administrator 
Clinical Project Manager 
Scientific Writer 
Director Global Engineering 
Communications Consultant 
Client Talent Acquisition Specialist 
Cell Culture Scientist/Senior Scientist 
Senior Manager, Clinical Trial Budget 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Laboratory technician for process development and clinical manufacturing 
Innovation Project Manager, Display Unit 
Nordic Medical Affairs Manager 
Production Director 
Key Account Manager, Europe and Asia